- ¥211bn
- ¥825bn
- ¥587bn
- 45
- 54
- 36
- 41
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 13.6 | ||
| PEG Ratio (f) | 0.94 | ||
| EPS Growth (f) | 16.89% | ||
| Dividend Yield (f) | 2.42% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.91 | ||
| Price to Tang. Book | 1.07 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.34 | ||
| EV to EBITDA | 10.1 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 2.24% | ||
| Return on Equity | 2.13% | ||
| Operating Margin | 2.75% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 442,516 | 455,559 | 494,789 | 545,199 | 586,785 | 643,793 | 657,653 | 6.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +3.05 | +73.03 | -30.76 | -63.68 | +123.04 | -8.32 | +16 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.
Directors
- Yoshihiko Sano PRE (75)
- Yasushi Ohyama MDR (59)
- Takehito Yogo MDR (52)
- Kyoetsu Kobayashi MDR (66)
- Toshiaki Masuda MDR (69)
- Kimihito Minoura MDR (49)
- Kenichi Nishida MDR (51)
- Kazuhiko Sano MDR (69)
- Tsuyoshi Yamazaki MDR (53)
- Kiyotaka Yoshioka MDR (68)
- Kenju Fujita DSL (65)
- Masayuki Ito DSL (63)
- Masanobu Iwasa DSL (63)
- Yasushi Kutsukawa DSL (64)
- Kaname Sadahiro DSL (56)
- Mitsutaka Ueda DSL (65)
- Hideto Nakamura DHR (63)
- Itsuo Akasaki OTH (67)
- Koki Hatakeyama OTH (62)
- Toshiya Kai OTH (61)
- Goichi Miyazumi OTH (52)
- Yozo Sawada OTH (74)
- Akio Shirasu OTH (60)
- Hiroshi Sudo OTH (59)
- Hiroshi Yoshida OTH (59)
- Toyoshi Yoshida OTH (58)
- Yoshiko Shimamori IND
- Yoshiko Tanaka IND (72)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- July 30th, 1948
- Public Since
- February 1st, 1987
- No. of Shareholders
- 62,816
- No. of Employees
- 38,117
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange- Shares in Issue
- 163,095,674
- Address
- 3-26, Senrioka shin-machi, SETTSU-SHI, 566-8510
- Web
- https://www.nipro.co.jp/
- Phone
- +81 663106909
- Auditors
- Kainan Audit Corporation
Upcoming Events for 8086
Nipro Corp Annual Shareholders Meeting
Q1 2026 Nipro Corp Earnings Release
Similar to 8086
Alfresa Holdings
Tokyo Stock Exchange
Asahi Intecc Co
Tokyo Stock Exchange
Aso International
Tokyo Stock Exchange
As One
Tokyo Stock Exchange
Atect
Tokyo Stock Exchange
FAQ
What is the Nipro share price?
As of Today at 22:18 UTC, shares in Nipro are trading at ¥1,306. This share price information is delayed by 15 minutes.
How has the Nipro share price performed this year?
Shares in Nipro last closed at ¥1,306 and the price had moved by +4.9% over the past 365 days. In terms of relative price strength the Nipro share price has outperformed the Nikkei 225 Index by +10.55% over the past year.
What are the analyst and broker recommendations for Nipro?
The overall consensus recommendation for Nipro is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Nipro dividend yield?
The Nipro dividend yield is 2.07% based on the trailing twelve month period.
Does Nipro pay a dividend?
Last year, Nipro paid a total dividend of ¥27, and it currently has a trailing dividend yield of 2.07%.Looking ahead, the next dividend pay date is 2025-06-01.
When does Nipro next pay dividends?
We do not have data on when Nipro is to next pay dividends. The historic dividend yield on Nipro shares is currently 2.07%.
How do I buy Nipro shares?
To buy shares in Nipro you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Nipro?
As of the previous close price of ¥1,306, shares in Nipro had a market capitalisation of ¥211bn.
Where are Nipro shares listed?
Here are the trading details for Nipro:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 8086
What kind of share is Nipro?
Based on an overall assessment of its quality, value and momentum Nipro is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Nipro share price forecast for 2025?
The analyst consensus target price for shares in Nipro is ¥1,536. That is 17.6% above the last closing price of ¥1,306.
Analysts covering Nipro currently have a consensus Earnings Per Share (EPS) forecast of ¥82 for the next financial year.
Find out moreWhat is the trend in the Nipro share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nipro. Over the past six months, its share price has outperformed the Nikkei 225 Index by +0.4%.
As of the last closing price of ¥1,306, shares in Nipro were trading -4.05% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Nipro PE Ratio?
The Nipro PE ratio based on its reported earnings over the past 12 months is 13.6. The shares last closed at ¥1,306.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Nipro?
Nipro's management team is headed by:
- Yoshihiko Sano - PRE
- Yasushi Ohyama - MDR
- Takehito Yogo - MDR
- Kyoetsu Kobayashi - MDR
- Toshiaki Masuda - MDR
- Kimihito Minoura - MDR
- Kenichi Nishida - MDR
- Kazuhiko Sano - MDR
- Tsuyoshi Yamazaki - MDR
- Kiyotaka Yoshioka - MDR
- Kenju Fujita - DSL
- Masayuki Ito - DSL
- Masanobu Iwasa - DSL
- Yasushi Kutsukawa - DSL
- Kaname Sadahiro - DSL
- Mitsutaka Ueda - DSL
- Hideto Nakamura - DHR
- Itsuo Akasaki - OTH
- Koki Hatakeyama - OTH
- Toshiya Kai - OTH
- Goichi Miyazumi - OTH
- Yozo Sawada - OTH
- Akio Shirasu - OTH
- Hiroshi Sudo - OTH
- Hiroshi Yoshida - OTH
- Toyoshi Yoshida - OTH
- Yoshiko Shimamori - IND
- Yoshiko Tanaka - IND